This announcement is a separate document:
奥赛康：华泰联合证券有限责任公司关于北京奥赛康药业股份有限公司重大资产置换及发行股份购买资产暨关联交易之2021年度持续督导意见暨持续督导总结报告
Osecon: Huatai United Securities Co., Ltd.'s 2021 Continued Supervision Opinions and Continued Supervision Summary Report on Beijing Aosaikang Pharmaceutical Co., Ltd.'s Major Asset Exchange and Issuance of Shares to Purchase Assets and Related Transaction
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated